Yang Q, Liang Y, Inoue-Hatanaka T, Koh Z, Ilkenhans N, Suman E
bioRxiv. 2025; .
PMID: 39763816
PMC: 11702609.
DOI: 10.1101/2024.12.16.628819.
Fritsch N, Aparicio-Soto M, Curato C, Riedel F, Thierse H, Luch A
Toxics. 2024; 12(11).
PMID: 39590982
PMC: 11598016.
DOI: 10.3390/toxics12110802.
Kust S, Ustiuzhanina M, Streltsova M, Shelyakin P, Kryukov M, Lutsenko G
Int J Mol Sci. 2024; 25(9).
PMID: 38731828
PMC: 11083986.
DOI: 10.3390/ijms25094609.
Martin K, Hammer Q, Perica K, Sadelain M, Malmberg K
Nat Rev Immunol. 2024; 24(9):680-693.
PMID: 38658708
DOI: 10.1038/s41577-024-01022-8.
Ko A, Coward V, Gokgoz N, Dickson B, Tsoi K, Wunder J
Cancers (Basel). 2022; 14(3).
PMID: 35158816
PMC: 8833772.
DOI: 10.3390/cancers14030548.
CD8HLADR Regulatory T Cells Change With Aging: They Increase in Number, but Lose Checkpoint Inhibitory Molecules and Suppressive Function.
Lukas Yani S, Keller M, Melzer F, Weinberger B, Pangrazzi L, Sopper S
Front Immunol. 2018; 9:1201.
PMID: 29915580
PMC: 5994398.
DOI: 10.3389/fimmu.2018.01201.
Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indications of Both Contact-Dependent and -Independent Activation.
Revenfeld A, Baek R, Jorgensen M, Varming K, Stensballe A
Int J Mol Sci. 2017; 18(7).
PMID: 28737722
PMC: 5536089.
DOI: 10.3390/ijms18071603.
Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire.
Ammann S, Lehmberg K, Zur Stadt U, Janka G, Rensing-Ehl A, Klemann C
Eur J Immunol. 2016; 47(2):364-373.
PMID: 27925643
PMC: 7163530.
DOI: 10.1002/eji.201646686.
Tetherin/BST-2: Restriction Factor or Immunomodulator?.
Li S, Barrett B, Guo K, Santiago M
Curr HIV Res. 2016; 14(3):235-46.
PMID: 26957198
PMC: 5466165.
DOI: 10.2174/1570162x14999160224102752.
Dynamic interaction between astrocytes and infiltrating PBMCs in context of neuroAIDS.
Richards M, Narasipura S, Kim S, Seaton M, Lutgen V, Al-Harthi L
Glia. 2014; 63(3):441-51.
PMID: 25331637
PMC: 4293283.
DOI: 10.1002/glia.22763.
Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?.
Kambayashi T, Laufer T
Nat Rev Immunol. 2014; 14(11):719-30.
PMID: 25324123
DOI: 10.1038/nri3754.
High metal ion levels after use of the ASR™ device correlate with development of pseudotumors and T cell activation.
Hailer N, Bengtsson M, Lundberg C, Milbrink J
Clin Orthop Relat Res. 2013; 472(3):953-61.
PMID: 24081666
PMC: 3916604.
DOI: 10.1007/s11999-013-3307-x.
Marked differences in CCR5 expression and activation levels in two South African populations.
Picton A, Shalekoff S, Paximadis M, Tiemessen C
Immunology. 2012; 136(4):397-407.
PMID: 22509959
PMC: 3401978.
DOI: 10.1111/j.1365-2567.2012.03592.x.
Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.
Costantino C, Ploegh H, Hafler D
J Immunol. 2009; 183(2):945-52.
PMID: 19553543
PMC: 2752291.
DOI: 10.4049/jimmunol.0900921.
Human regulatory T cells and autoimmunity.
Costantino C, Baecher-Allan C, Hafler D
Eur J Immunol. 2008; 38(4):921-4.
PMID: 18395861
PMC: 2752283.
DOI: 10.1002/eji.200738104.
Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT.
Choi J, Walker J, Talbert-Slagle K, Wright P, Pober J, Alexander L
J Virol. 2005; 79(17):11194-204.
PMID: 16103171
PMC: 1193601.
DOI: 10.1128/JVI.79.17.11194-11204.2005.
Recirculation of lymphocyte subsets (CD5+, CD4+, CD8+, SBU-T19+ and B cells) through gut and peripheral lymph nodes.
Kimpton W, Washington E, Cahill R
Immunology. 1989; 66(1):69-75.
PMID: 15493265
PMC: 1385122.
A carbohydrate neoepitope that is up-regulated on human mononuclear leucocytes by neuraminidase treatment or by cellular activation.
Quinn M, Swain S, Parkos C, Jutila K, Siemsen D, Kurk S
Immunology. 2001; 104(2):185-97.
PMID: 11683959
PMC: 1783300.
DOI: 10.1046/j.1365-2567.2001.01300.x.
T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.
Mannie M
Immunol Res. 2001; 23(1):1-21.
PMID: 11417857
DOI: 10.1385/IR:23:1:01.
Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists.
Fisher A, Le Couteur D
Drug Saf. 2001; 24(1):39-57.
PMID: 11219486
DOI: 10.2165/00002018-200124010-00004.